1
|
Vašků V, Fialová P, Vašků A. New Genetic Markers of Skin T-Cell Lymphoma Treatment. Genes (Basel) 2024; 15:358. [PMID: 38540417 PMCID: PMC10970540 DOI: 10.3390/genes15030358] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2023] [Revised: 03/06/2024] [Accepted: 03/11/2024] [Indexed: 06/14/2024] Open
Abstract
AIM Cutaneous T-cell lymphomas (CTCL) can be described as chronic skin inflammation lesions with the content of malignant T cells and they are considered to be T-cell-mediated skin diseases. CD147 is recognized as a 58-kDa cell surface glycoprotein of the immunoglobulin superfamily; it can induce the synthesis of MMPs (matrix metalloproteinases) on the surface of tumor cells where it was originally identified. It can also function in adjacent tumor fibroblasts using CD147-CD147 interactions. The polymorphism rs8259 T/A is situated in the untranslated region (3'UTR) of the CD147 gene. HLA DRB1*1501 takes part in the process of presentation and recognition of different antigens to T cells. It can be expressed by antigen-presenting cells-macrophages, dendritic cells, and B cells. The aim of the study is to test genotype-phenotype associations of both polymorphisms including therapy in a large cohort of CTCL patients. MATERIALS AND METHODS A final total of 104 CTCL patients were enrolled in the study. For the first remission at the clinic department, they were treated by means of local skin-directed therapy, phototherapy, and systemic therapy. Genomic DNA was isolated from peripheral blood leukocytes. A standard technique using proteinase K was applied. The polymorphisms rs8259 T/A (CD147 gene) and rs3135388 (HLA DRB1*1501) were detected through standard PCR-restriction fragment length polymorphism methods. RESULTS The severity of the disease (patients with parapsoriasis, stages IA and IB, vs patients with stages IIB, IIIA, and IIIB) was associated with the CD147 genotype: the AA variant was 3.38 times more frequent in more severe cases, which reflects the decision on systemic therapy (p = 0.02, specificity 0.965). The AA genotype in the CD147 polymorphism was 12 times more frequent in patients who underwent systemic therapy of CTCL compared to those not treated with this therapy (p = 0.009, specificity 0.976). The same genotype was also associated with radiotherapy-it was observed 14 times more frequently in patients treated with radiotherapy (p = 0.009, specificity 0.959). In patients treated with interferon α therapy, the AA genotype was observed to be 5.85 times more frequent compared to the patients not treated with interferon therapy (p = 0.03, specificity 0.963). The HLA DRB1*1501 polymorphism was associated with local skin-directed therapy of CTCL. The CC genotype of the polymorphism was observed to be 3.57 times more frequent in patients treated with local therapy (p = 0.008, specificity 0.948). When both polymorphisms had been calculated together, even better results were obtained: the AACC double genotype was 11 times more frequent in patients with severe CTCL (p = 0.009, specificity 0.977). The TACT double genotype was associated with local skin-directed therapy (0.09 times lower frequency, p = 0.007, sensitivity 0.982). The AACC genotype was 8.9 times more frequent in patients treated by means of systemic therapy (p = 0.02, specificity 0.976) and as many as 18.8 times more frequent in patients treated with radiotherapy (p = 0.005, specificity 0.969). Thus, the AACC double genotype of CD147 and DRB1*1501 polymorphisms seems to be a clinically highly specific marker of severity, systemic therapy and radiotherapy of patients with T-cell lymphoma. CONCLUSION Although genotyping results were not known during the treatment decision and could not modify it, the clinical decision on severity and therapy reflected some aspects of the genetic background of this complicated T-cell-associated disease very well.
Collapse
Affiliation(s)
- Vladimír Vašků
- 1st Department of Dermatovenerology, St. Anne’s University Hospital, Faculty of Medicine, Masaryk University, 60200 Brno, Czech Republic; (V.V.); (P.F.)
| | - Petra Fialová
- 1st Department of Dermatovenerology, St. Anne’s University Hospital, Faculty of Medicine, Masaryk University, 60200 Brno, Czech Republic; (V.V.); (P.F.)
| | - Anna Vašků
- Department of Pathological Physiology, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic
| |
Collapse
|
2
|
Almaani N, Farhan F, Bani Hamad S, Abuhawileh EA, Koubaitary L, Ahram M, Aladily TN. Genetic predisposition to early mycosis fungoides: investigating genetic polymorphisms in tissue-resident memory T-cell genes. J Int Med Res 2024; 52:3000605241239034. [PMID: 38546260 PMCID: PMC10981233 DOI: 10.1177/03000605241239034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2024] [Accepted: 02/26/2024] [Indexed: 04/01/2024] Open
Abstract
OBJECTIVES Mycosis fungoides (MF) is the most common cutaneous T-cell lymphoma; it arises from tissue-resident memory T-cells (TRM). In the present study, we investigated potential functional genetic variations that may predispose MF development. METHODS A case-control study was conducted using whole-exome sequencing, with a focus on genes that are essential to TRM function. RESULTS We included 21 patients and 19 healthy subjects in the study. Single nucleotide polymorphisms in the following genes were significantly more common in patients than in healthy subjects: GZMB, HLA-DRB1, CD103, and NOTCH1. Moreover, the number of patients carrying single nucleotide polymorphisms in LAG3, NR4A2, and CD26L was significantly greater in the patient group than in the control group. CONCLUSIONS The presence of genetic variations in one or more TRM functional gene may predispose patients to develop MF. Further studies involving a larger patient population and a comparative analysis of protein expression will be necessary to validate these findings.
Collapse
Affiliation(s)
- Nour Almaani
- Department of Dermatology, The University of Jordan, Amman, Jordan
| | - Fatima Farhan
- Department of Health Data Analysis, Electronic Health Solution, Amman, Jordan
| | | | | | - Lana Koubaitary
- Department of Pathology, The University of Jordan, Amman, Jordan
| | - Mamoun Ahram
- Department of Physiology and Biochemistry, The University of Jordan, Amman, Jordan
| | - Tariq N Aladily
- Department of Pathology, The University of Jordan, Amman, Jordan
| |
Collapse
|
3
|
Blanco G, López‐Aventín D, Pujol RM, Gómez‐Llonín A, Puiggros A, López‐Sánchez M, Estrach T, García‐Muret MP, López‐Lerma I, Servitje O, Bellosillo B, Muro M, Espinet B, Rabionet R, Gallardo F. High-throughput RNA sequencing of the T cell receptor alpha and beta chains for simultaneous clonality and biological analyses in Sezary syndrome. J Clin Lab Anal 2023; 37:e24982. [PMID: 38115685 PMCID: PMC10756948 DOI: 10.1002/jcla.24982] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2022] [Accepted: 10/17/2023] [Indexed: 12/21/2023] Open
Abstract
BACKGROUND Previous investigations pointed out a role for antigen stimulation in Sezary syndrome (SS). High-throughput sequencing of the T cell receptor (TR) offers several applications beyond diagnostic purposes, including the study of T cell pathogenesis. METHODS We performed high-throughput RNA sequencing of the TR alpha (TRA) and beta (TRB) genes focusing on the complementarity-determining region 3 (CDR3) in 11 SS and one erythrodermic mycosis fungoides (MF) patients. Five psoriasis patients were employed as controls. Peripheral blood CD4+ cells were isolated and RNA sequenced (HiSeq2500). High-resolution HLA typing was performed in neoplastic patients. RESULTS Highly expanded predominant TRA and TRB CDR3 were only found in SS patients (median frequency: 94.4% and 93.7%). No remarkable CDR3 expansions were observed in psoriasis patients (median frequency of predominant TRA and TRB CDR3: 0.87% and 0.69%, p < 0.001 compared to SS). CDR3 almost identical to the predominant were identified within each SS patient and were exponentially correlated with frequencies of the predominant CDR3 (R2 = 0.918, p < 0.001). Forty-six different CDR3 were shared between SS patients displaying HLA similarities, including predominant TRA and TRB CDR3 in one patient that were found in other three patients. Additionally, 351 antigen matches were detected (Cytomegalovirus, Epstein-Barr, Influenza virus, and self-antigens), and the predominant CDR3 of two different SS patients matched CDR3 with specificity for Influenza and Epstein-Barr viruses. CONCLUSIONS Besides detecting clonality, these findings shed light on the nature of SS-related antigens, pointing to RNA sequencing as a useful tool for simultaneous clonality and biological analysis in SS.
Collapse
Affiliation(s)
- Gonzalo Blanco
- Grup de Recerca Translacional en Neoplàsies Hematològiques, Cancer Research ProgrammeIMIM‐Hospital del MarBarcelonaSpain
- Laboratori de Citogenètica Molecular, Servei de PatologiaHospital del MarBarcelonaSpain
- Karches Center for Oncology ResearchThe Feinstein Institutes for Medical Research, Northwell HealthManhassetNew YorkUSA
| | - Daniel López‐Aventín
- Servei de DermatologiaHospital del MarBarcelonaSpain
- Programa de Doctorat en Medicina, Departament de MedicinaUniversitat Autònoma de Barcelona (UAB)BarcelonaSpain
| | - Ramon M. Pujol
- Servei de DermatologiaHospital del MarBarcelonaSpain
- Grup de Recerca en Malalties Inflamatòries i Neoplàsiques Dermatològiques, Inflammation and Cardiovascular Disorders Research ProgrammeIMIM‐Hospital del MarBarcelonaSpain
| | - Andrea Gómez‐Llonín
- Grup de Recerca Translacional en Neoplàsies Hematològiques, Cancer Research ProgrammeIMIM‐Hospital del MarBarcelonaSpain
- Laboratori de Citogenètica Molecular, Servei de PatologiaHospital del MarBarcelonaSpain
- Laboratori de Recerca Translacional en Microambient TumoralCancer Research ProgrammeBarcelonaSpain
| | - Anna Puiggros
- Grup de Recerca Translacional en Neoplàsies Hematològiques, Cancer Research ProgrammeIMIM‐Hospital del MarBarcelonaSpain
- Laboratori de Citogenètica Molecular, Servei de PatologiaHospital del MarBarcelonaSpain
| | - Manuela López‐Sánchez
- Servicio de InmunologíaHospital Clínico Universitario Virgen de la Arrixaca‐IMIBMurciaSpain
| | - Teresa Estrach
- Servei de Dermatologia, Hospital Clínic, IDIBAPSUniversitat de BarcelonaBarcelonaSpain
| | | | | | | | - Beatriz Bellosillo
- Grup de Recerca Clínica Aplicada en Neoplàsies Hematològiques, Cancer Research ProgrammeIMIM‐Hospital del MarBarcelonaSpain
- Laboratori de Biologia Molecular, Servei de PatologiaHospital del MarBarcelonaSpain
| | - Manuel Muro
- Servicio de InmunologíaHospital Clínico Universitario Virgen de la Arrixaca‐IMIBMurciaSpain
| | - Blanca Espinet
- Grup de Recerca Translacional en Neoplàsies Hematològiques, Cancer Research ProgrammeIMIM‐Hospital del MarBarcelonaSpain
- Laboratori de Citogenètica Molecular, Servei de PatologiaHospital del MarBarcelonaSpain
| | - Raquel Rabionet
- Departament de Genètica, Microbiologia i EstadísticaUniversitat de BarcelonaBarcelonaSpain
- Institut de Recerca Sant Joan de DéuHospital Sant Joan de DéuBarcelonaSpain
- Institut de Biomedicina (IBUB)Universitat de BarcelonaBarcelonaSpain
- Centro de Investigaciones Biomédicas en Red de Enfermedades Raras (CIBERER)Instituto de Salud Carlos III (ISCIII)MadridSpain
| | - Fernando Gallardo
- Grup de Recerca Translacional en Neoplàsies Hematològiques, Cancer Research ProgrammeIMIM‐Hospital del MarBarcelonaSpain
- Servei de DermatologiaHospital del MarBarcelonaSpain
| |
Collapse
|
4
|
Stadler R, Hain C, Cieslak C, Stranzenbach R. Molecular pathogenesis of cutaneous lymphoma-Future directions. Exp Dermatol 2020; 29:1062-1068. [PMID: 33090576 DOI: 10.1111/exd.14211] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2020] [Revised: 09/18/2020] [Accepted: 10/01/2020] [Indexed: 12/18/2022]
Abstract
The pathogenesis of cutaneous T-cell lymphomas is not clear. In recent years, the genetic changes in CTCL were explored. The detected mutations showed a great deal of heterogeneity between individual patients. The studies documented various copy number variations (CNV) and single nucleotide variations (SNV) in multiple genes involved in multiple signalling pathways. Recurrently mutated signalling pathways include JAK-STAT, MAPK, T-cell receptor, TNF receptor and NFκB signalling. In the period between 2018 and today, additional studies towards the genetic changes in CTCL were carried out. Genetic changes in gamma delta T-cell lymphoma are also shown in genes of the JAK-STAT, MAPK, MYC and chromatin signalling pathways. These studies might indicate a shift away from targeted sequencing approaches towards whole-genome sequencing. This approach demands additional resources in terms of funding but has the advantage of finding mutations in non-coding regions. These mutations were neglected for a long time, but as shown in contemporary research these regions harbour highly recurrent mutations affecting gene expression and regulation. Nevertheless, the detection of specific molecular changes in known pathways enables considerations for targeted therapies.
Collapse
Affiliation(s)
- Rudolf Stadler
- University Clinic for Dermatology, Johannes Wesling Medical Centre, UKRUB, University of Bochum, Minden, Germany
| | - Carsten Hain
- Center of Biotechnology, University of Bielefeld, Bielefeld, Germany
| | - Cassandra Cieslak
- University Clinic for Dermatology, Johannes Wesling Medical Centre, UKRUB, University of Bochum, Minden, Germany
| | - René Stranzenbach
- University Clinic for Dermatology, Johannes Wesling Medical Centre, UKRUB, University of Bochum, Minden, Germany
| |
Collapse
|
5
|
Chen B, Zheng Y, Zhu J, Liang Y. SHARPIN overexpression promotes TAK1 expression and activates JNKs and NF-κB pathway in Mycosis Fungoides. Exp Dermatol 2019; 28:1279-1288. [PMID: 31461795 DOI: 10.1111/exd.14026] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2019] [Revised: 08/02/2019] [Accepted: 08/23/2019] [Indexed: 12/16/2022]
Abstract
Mycosis Fungoides (MF) is the most common subtype of cutaneous T-cell lymphomas (CTCL). Shank-associated RH domain-interacting protein (SHARPIN) participates in the initiation and development of multiple tumors. However, the clinical significance of SHARPIN in MF hasn't been investigated. The c-Jun N-terminal kinases (JNKs) pathway is a member of mitogen-activated protein kinases (MAPKs). Its dysregulation is observed in various tumors including CTCL, whereas the roles of JNKs pathway in MF remain largely unknown, the relationship between SHARPIN and JNKs pathway remains elusive. Herein, we showed that upregulated expression of SHARPIN was related to poor prognosis of MF patients. In vitro experiments found increased SHARPIN expression and activation of JNKs pathway in MF cell line MyLa2059. SHARPIN induced transforming growth factor β activated kinase-1 (TAK1) transcription, which is an upstream kinase of JNKs, NF-κB and p38 pathway, leading to activation of JNKs and NF-κB pathway. SHARPIN also promoted p38 signalling independent of TAK1 expression, by which overexpression of SHARPIN induced cell proliferation, inhibited apoptosis, enhanced migration and invasion of MyLa2059. Our work provided direct evidences for effects of SHARPIN on JNKs and NF-κB pathway, and the contributing roles of JNKs, NF-κB and p38 pathway regulated by SHARPIN in the development of MF.
Collapse
Affiliation(s)
- Biao Chen
- Department of Dermatology, Cosmetology and Venereology, Shenzhen Hospital, Southern Medical University, Shenzhen, China
| | - Yan Zheng
- Department of Dermatology, Cosmetology and Venereology, Shenzhen Hospital, Southern Medical University, Shenzhen, China
| | - Jingna Zhu
- Department of Dermatology, Cosmetology and Venereology, Shenzhen Hospital, Southern Medical University, Shenzhen, China
| | - Yanhua Liang
- Department of Dermatology, Cosmetology and Venereology, Shenzhen Hospital, Southern Medical University, Shenzhen, China
| |
Collapse
|
6
|
Pediatric mycosis fungoides: a study of the human leukocyte antigen system among Israeli Jewish patients. Arch Dermatol Res 2017; 309:851-856. [DOI: 10.1007/s00403-017-1783-7] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2017] [Revised: 09/06/2017] [Accepted: 09/14/2017] [Indexed: 10/18/2022]
|
7
|
Brazzelli V, Rivetti N, Croci GA, Barbarini G, Vassallo C, Paulli M, Borroni G. Long-term remission of erythrodermic mycosis fungoides after persistent control of hepatitis B infection. J Eur Acad Dermatol Venereol 2016; 31:e108-e110. [PMID: 27422529 DOI: 10.1111/jdv.13837] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- V Brazzelli
- Department of Clinical-Surgical, Diagnostic and Pediatric Science, Institute of Dermatology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
| | - N Rivetti
- Department of Clinical-Surgical, Diagnostic and Pediatric Science, Institute of Dermatology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
| | - G A Croci
- Anatomic Pathology Unit, Department of Molecular Medicine, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
| | - G Barbarini
- Division of Tropical Medicine, Department of Infectious Diseases, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
| | - C Vassallo
- Department of Clinical-Surgical, Diagnostic and Pediatric Science, Institute of Dermatology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
| | - M Paulli
- Anatomic Pathology Unit, Department of Molecular Medicine, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
| | - G Borroni
- Department of Clinical-Surgical, Diagnostic and Pediatric Science, Institute of Dermatology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
| |
Collapse
|
8
|
Cutaneous T cell Lymphoma: an Update on Pathogenesis and Systemic Therapy. Curr Hematol Malig Rep 2015; 10:468-76. [DOI: 10.1007/s11899-015-0293-y] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
|
9
|
Brazzelli V, Rivetti N, Badulli C, Carugno A, Cananzi R, De Silvestri A, Martinetti M, Borroni G. Mycosis fungoides: association of KIR ligands and HLA-DQB1*05 with bad prognosis of the disease. J Eur Acad Dermatol Venereol 2015; 30:266-9. [DOI: 10.1111/jdv.13083] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2014] [Accepted: 01/27/2015] [Indexed: 11/27/2022]
Affiliation(s)
- V. Brazzelli
- Department of Clinical-Surgical, Diagnostic and Pediatric Science; Institute of Dermatology; Pavia Italy
| | - N. Rivetti
- Department of Clinical-Surgical, Diagnostic and Pediatric Science; Institute of Dermatology; Pavia Italy
| | - C. Badulli
- Immunogenetic Laboratory; Immunohematology Service and Trasfusional Medicine; Pavia Italy
| | - A. Carugno
- Department of Clinical-Surgical, Diagnostic and Pediatric Science; Institute of Dermatology; Pavia Italy
| | - R. Cananzi
- Department of Clinical-Surgical, Diagnostic and Pediatric Science; Institute of Dermatology; Pavia Italy
| | - A. De Silvestri
- Biometry and Statistics; Fondazione IRCCS Policlinico San Matteo; University of Pavia; Pavia Italy
| | - M. Martinetti
- Immunogenetic Laboratory; Immunohematology Service and Trasfusional Medicine; Pavia Italy
| | - G. Borroni
- Department of Clinical-Surgical, Diagnostic and Pediatric Science; Institute of Dermatology; Pavia Italy
| |
Collapse
|
10
|
Hodak E, Amitay-Laish I. Response to: "Tumor stage mycosis fungoides in nonblood-related family members". J Am Acad Dermatol 2014; 71:1002-3. [PMID: 25437961 DOI: 10.1016/j.jaad.2014.04.056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2014] [Accepted: 04/22/2014] [Indexed: 11/18/2022]
Affiliation(s)
- Emmilia Hodak
- Department of Dermatology, Rabin Medical Center, Beilinson Hospital, Petach Tikva, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
| | - Iris Amitay-Laish
- Department of Dermatology, Rabin Medical Center, Beilinson Hospital, Petach Tikva, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| |
Collapse
|